Fresenius | FRE - Przychody Ze Sprzedaży





Obroty Zmiana Data
Akzo Nobel EUR 2.59B 200M 2026-06
Alcon AG USD 2.69B 10M 2026-03
AstraZeneca USD 15.38B 90M 2026-06
BASF EUR 17.21B 1.19B 2026-06
Bayer EUR 10.87B 2.54B 2026-06
Beiersdorf EUR 2.45B 30M 2026-06
DaVita Healthcare Partners USD 3.55B 130M 2026-06
Demant DKK 6.25B 800M 2025-12
E.ON EUR 21.82B 630M 2026-03
Essilor EUR 14.82B 351M 2026-06
Fresenius EUR 5.95B 210M 2026-06
Fresenius Medical Care EUR 4.86B 250M 2026-06
Getinge SEK 8.38B 1000K 2026-06
Givaudan CHF 3.61B 256M 2025-12
GlaxoSmithKline GBP 8.41B 781M 2026-06
GN Store Nord DKK 3.85B 830M 2026-03
GRIFOLS EUR 1.87B 170M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.13B 120M 2026-03
Novartis USD 14.41B 1.3B 2026-06
Philips EUR 4.36B 450M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
RWE EUR 4.34B 220M 2026-03
Sanofi EUR 11.95B 710M 2026-06
Smith & Nephew USD 1.6B 1.58B 2026-06